Podcasts about nanome

Check out the next episode of our podcast, Under the Surface! In episode 6, Revolutionizing Nanoscale Visualization, we talk to Nanome CEO and co-founder Steve McCloskey. In a virtual rollercoaster of a conversation, he shares Nanome's scrappy beginnings, the challenge and excitement of bringing new ways of interacting with models to the science community, and paints a vivid picture of an exciting element of the future of molecular modeling.  It's Reality Jim, but not as we know it… Interested in giving this a test drive?  Contact hello@nanome.ai to set up a demo with Nanome.

Con il quarto episodio, NanoMe arriva a destinazione. In quest'ultimo episodio ci arrampicheremo su di un'impalcatura ultra-millenaria... Seguiamolo, basta un play!

In questo terzo episodio NanoMe ci trasporta tra le onde dell'Oceano Atlantico all'interno di un pesce. Conosci il Plasticene? Premi play e scoprilo con noi.

Continua il nanoscopico viaggio nella materia con NanoMe. Cosa si nasconde dentro un uovo? Dalle nanostrutture dei gusci agli incontri ravvicinati con i batteri di salmonella... E tu, sai quali sono le precauzioni necessarie contro questi microscopici nemici?

I vincitori del contest ChiMiAscolta fanno breccia tra le voci di Chemisonoperso. Questa è una nano-storia raccontata dalle voci di Lucia Zanetti e Giulia Moro, è il racconto di ciò che è accaduto quel giorno in cui entrando in laboratorio… premi play per saperne di più! (Audio editing: Leonardo Polloniato)

Find out more and see demos at Nanome.aiSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Our guest on The XR MAG Show today is Keita Funakawa, Cofounder at Nanome Inc Keita's passion lies at the intersection of technology, media, and science. He graduated from UC San Diego with a B.S. in Management Science (Quantitative Economics) and a minor in Visual Arts Digital Media. He co-founded Nanome in 2015 and now leads company operations. Nanome enables expert scientists, students, and hobbyists to design and simulate molecules in Virtual Reality. Nanome is the next step in computational/medicinal chemistry, structural biology, and beyond. I'm glad that Keita Funakawa agreed to take some time out of his schedule to talk and share his experience on the XR Magazine show! In this episode, you will learn: The technology behind Nanome and how it is used to design and simulate molecules in Virtual Reality What are the greatest challenges in creating a tool like Nanome and the implementation of their new feature: voice recognition and recording How do Nanome's technology benefit scientists, students, and hobbyists in the field of computational/medicinal chemistry and structural biology How chemistry and the field of scientific research, in general, are pushing the boundaries of immersive technologies Please let me know if you have any questions about this episode or what guests you would like me to bring next!

Tune in to see Application Scientists from Nanome discuss how drug design and discovery can be improved across teams using XR. From pocket characterization to docking, and more, teams from all over the world can still come together in the space through the power of XR toolsKeita FunakawaCOONanomeKeita Funakawa is Nanome's COO. Keita's passion lies at the intersection of emerging technologies, digital arts, and science. He graduated from UC San Diego with a B.S. in Management Science (Quantitative Economics) and a minor in Visual Arts Digital Media. He co-founded Nanome in 2015 and now leads company operations.Mike BishopDrug Discovery ConsultantNanomeMike Bishop started Bishop Drug Discovery Consulting in 2019 after 26 years as a medicinal chemist with GSK. From 2001 to 2014 he directed a department of medicinal chemists and DMPK scientists with a focus on metabolic diseases, identifying ~10 clinical development candidates. From 2014 to 2019, Mike served as a Director in GSK's Discovery Partnerships with Academia (DPAc) unit, with responsibilities for thorough vetting of research opportunities across multiple therapeutic areas, building collaborative workplans and leading joint research programs with academic investigators. Mike earned a B.A. in chemistry from Rice University in Houston, TX, worked in the petrochemical industry with Amoco Chemical in Texas City, TX for two years, and then returned to Rice, earning a Ph.D. in organic chemistry under the guidance of Dr. Marco Ciufolini.Jonathon GastSenior Application ScientistNanomeJonathon Gast has a background in pharmacology, informatics, and medicinal chemistry. He completed his Ph.D. in molecular pharmacology at Purdue University with a focus on the creation of informatic approaches for the determination of mechanisms of action of synthetic lethal combinations. As an applications scientist at Nanome, he communicates with customers to understand their research objectives to create novel solutions through Nanome. This includes the creation of customized software, on-site training, or online demonstrations.

In this webinar, Dr. Seth Harris, Director of Computational Structural Biology & Senior Principal Scientist at Genentech, talks about GYST, the XR-integrated system developed by Genentech to efficiently manage large structural datasets. At Genentech, the in-house GYST platform is used to explore annotated structural datasets and rapidly get insights from large amounts of structural information.GYST integrates Nanome in its systems and allows researchers to access information, and manipulate and visualize data in the immersive virtual reality environment. During the webinar, Dr. Harris will go over the collaboration between scientists at Genentech and the Nanome team that led to the creation of customized GYST plugins.Highlights:- Large-scale data extracts and annotations of structural features can accelerate drug discovery and research- Our in-house platform GYST creates such datasets and enables their exploration by a broad range of researchers, while also provisioning information for machine-learning models- Custom plugins enable seamless integration of Nanome as a visualization and analytical component in this system

This week we discuss our first impressions on actually using the Quest Pro! More information about Nanome v1.24 and Quest Pro Launch of Nanomehttps://nanome.ai/blog/meta-quest-pro-and-a-new-version-of-nanome-(v1.24)

https://www.oculus.com/blog/meta-quest-pro-price-release-date/https://nanome.ai/blog/meta-quest-pro-and-a-new-version-of-nanome-(v1.24)

 we're joined by Dr. Andrey Kovalevsky, Senior Scientist in Structural Biology & Biochemistry at Oak Ridge National Laboratory. Andrey and his team used neutrons and x-rays to map part of the internal structure of the coronavirus to create an accurate 3-D model. Specifically, the scientists mapped the main protease (Mpro), an enzyme involved in the virus replication, to which they had added a preliminary small molecule discovered using high-speed computer screening and virtual reality (VR). Using the MedChem tool in Nanome to look at the enzyme model, the scientists virtually constructed different small molecules by modifying their structures to see if any newly designed compounds could fit, or bind, to a key site on the Mpro enzyme surface. A strong enough binding could inhibit, or block, the enzyme from functioning, which is vital to stopping the virus from multiplying in patients with COVID-19. References: Kneller et al. (2021). Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease. J. Med. Chem. 64, 8, 4991–5000. DOI: 10.1021/acs.jmedchem.1c01475 https://neutrons.ornl.gov/content/jou...https://www.pfizer.com/news/press-rel...https://www.rcsb.org/structure/7SI9

Discngine Labs: Virtual Reality for Structure-Based Drug DiscoveryEver wondered how Virtual Reality for Drug Design looks like in practice?  In the second session of our Discngine Labs, they host industry experts Wilian Cortopassi and Dr. Rishi Gupta from Novartis Institutes for BioMedical Research (NIBR) will present the “NIBR”Verse: the multidimensional space that brings together data and peers from all over the world in a single (virtual) place for effective collaborations in structure-based drug design. The presentation will be followed by the panel discussion on the current and future opportunities of Virtual Reality for Drug Discovery. Steve McCloskey, from the leading VR software company Nanome, will chair the discussion where industry experts and early adopters will share their thoughts and experiences on the topic.  Recording with video here: https://www.discngine.com/event/2022/06/23/discngine-labs-virtual-reality-for-collaborative-sbdd

Meta is shutting down one of its biggest VR games — but only for Quest 1 ownershttps://www.theverge.com/2022/8/7/23295691/meta-quest-1-population-one-shutting-down-biggest-vr-game-virtual-reality-battle-royaleMajor chemical database investigates hundreds of suspicious crystal structureshttps://www.nature.com/articles/d41586-022-02100-4New plugins from Nanome https://blog.matryx.ai/hot-new-plugins-for-hot-new-summer-250ef97a23cb

Dr. Michael Kuiper, a bio-molecular modeler at an Australian government research lab (Data61/CSIRO), is using Nanome & VR to analyze and help against the fight with the Coronavirus (COVID-19). Dr. Kuiper's colleagues at CSIRO are working on a vaccine at Geelong, and also some diagnostics at VIDRL (Victorian Infectious Diseases Reference Laboratory). Dr. Kuiper is generating models and analyzing molecular simulations in Nanome that could help gain insights into potential vaccines. Relevant articles/references to info above:https://www.csiro.au/en/News/News-releases/2020/CSIRO-scientists-start-work-on-coronavirushttps://www.goldcentralvictoria.com.au/news/current-events/100839-contained-csiro-lab-to-tackle-coronavirusMore info on the corona virus protease: http://pdb101.rcsb.org/motm/242If you'd like to see the structures in this livestream for yourself, you can load them from within Nanome via the PDB code 6LU7. Nanome is free to download through Oculus, Steam, Sidequest, or nanome.ai/setup

Nanome scientists are joined by Dr. Robert Pearlstein and Dr. Hongbin Wan, of Novartis, who share with us their recent publication on the application of biodynamics theory to characterize the structural dynamics of substrate-induced activation under non-equilibrium conditions. Biodynamics is a first principles multi-scale physics-based theory on the general mechanisms by which cellular functions are conveyed by dynamic multi-molecular/ionic systems and by which molecular and multi-molecular systems are powered by covalent and non-covalent forms of free energy (solvation free energy in the latter case). In this video, we cover the transduction of solvation free energy into dynamic molecular structure and drug-target binding exemplified by COVID Mpro inhibition.Reference: Wan, H., Aravamuthan, V. & Pearlstein, R. A. Probing the dynamic structure-function and structure-free energy relationships of the corona virus main protease with Biodynamics theory. http://biorxiv.org/lookup/doi/10.1101... (2020) doi:10.1101/2020.07.19.211185.

In this webinar Zoran Radić, Adjunct Professor at UC San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, shares insights into the catalytic core of Acetylcholinesterase and the new perspective on molecular analysis enabled by Virtual Reality.Atomic details of molecular 3D structures reveal the basis for understanding the catalytic power of enzyme molecules. This is why the correct perception of macromolecular architecture is greatly facilitated by immersive visualization and molecule manipulation in VR.When offending inhibitors compromise the optimally evolved geometry of enzymes finding out appropriate correcting tools becomes a challenge. Prof. Radić peek into the active center of one of the most powerful biological catalysts, the enzyme Acetylcholinesterase, and dissect approaches his research team uses to recover enzyme catalytic activity upon covalent modification by some of the most toxic inhibitors, such as Novichok organophosphate poisons.Highlights: - Understanding spatial impaction of Novichok-inhibited acetylcholinesterase is greatly facilitated by VR- 3D structures of Acetylcholinesterase help explain its catalysis and provide a template for structure-based design while revealing an unexpected paradox- Structure-based analysis aided by VR accelerates the creation and refinement of antidotes against acetylcholinesterase poisoning

Jackie Von Salm, PhD is the Co-Founder & Chief Scientific Officer PsileraWe coverWhy psychedelic research is so promising & what's on the horizon.Overcoming the challenges of communicating scientific research to investorsEasy ways to improve spatial awareness of chemists and the impact that brings to the labHow Psilera is using Nanome to filter compoundshttps://www.linkedin.com/in/jvonsalm/https://www.psilera.com/

This week host Derek E. Silva joins  Steve McCloskey, CEO of Nanome, a company building VR solutions for Scientists and Engineers working at the nanoscale. They dive into the early days Bitcoin, DAOs, and building the decentralized science metaverse.

Qualcomm's new Metaverse fund, AR/VR headset growth, and SNAP's BCI acquisitionSNAP Acquires NextMind to Drive Augmented Reality Researchhttps://www.nasdaq.com/articles/snap-acquires-nextmind-to-drive-augmented-reality-research?ampAugmented And Virtual Reality Headset Shipments Grew 92% In 2021https://www.alistdaily.com/technology/virtual-reality-headset-market-sees-unprecedented-growth-in-2021/amp/Qualcomm Sets Up $100M Fund for Metaverse Investmentshttps://www.coindesk.com/business/2022/03/24/qualcomm-sets-up-100m-fund-for-metaverse-investments/1.23.2 Patch, Nanome roadmap for the rest of 2022, and Nanome 2.0https://blog.matryx.ai/1-23-2-patch-nanome-roadmap-for-the-rest-of-2022-and-nanome-2-0-2206c2e1a7ab

Discussion about seqster, our neighbor joins decentralized trials & research alliance (dtra) to democratize and accelerate clinical trialshttps://www.prnewswire.com/news-releases/seqster-joins-decentralized-trials--research-[…]o-democratize-and-accelerate-clinical-trials-301491744.htmlNew Partnership Between Molecule, Apollo, and VitaDAOhttps://www.lifespan.io/news/new-partnership-between-molecule-apollo-and-vitadao/Apple Reportedly Completes Production Tests for AR/VR Headsethttps://www.macrumors.com/2022/02/21/apple-completes-ar-vr-headset-production-tests/Meta AI Concept: Create VR Worlds By Just Describing What You Wanthttps://uploadvr.com/meta-builderbot-ai-concept/why does the scientific metaverse start at the molecular scale or need to be atomically precise?what other industries can Nanome apply towhat other scientific metaverses are there besides atomically precise oneshow do we go from 1-100 nanometers and beyond

A warm welcome back to another episode of Good Vibes with Vive! Today we're bringing you something a little different: in honor of the closing of 2021 and the final episode of this season, this installment is dedicated to the nine incredible guests who have previously shared their expertise and wisdom with us. We asked each of them to share their professional and personal takeaways for 2021 and how they predict VR will make an impact on society in 2022! Key Points From This Episode: Hear how Inga Petryaevskaya, founder and CEO of Tvori, sees VR blooming in productivity and daily activity spaces. Dr. Ramses Alcaide of Neurable comments on empathy and harnessing brain signals to interact with the digital world.  Gabriel Jones, co-founder and CEO of Proprio Vision, shares the exciting ways VR will be adopted more into the healthcare sector.  Erica Woolsey, CEO and founder of Hydrous, dives into increasing accessibility and lowering barriers to entry.  What Kyle Jackson, CEO and founder of Tailspin's key learnings are; coming from a people-first perspective. Hear CEO and founder of Prisms of Reality, Anurupa Ganguly's hugely positive results in reimagined math education through VR. Hear from Keita Funakawa, co-founder and COO of Nanome, about how AR technology will soon give society what it wants. Some big predictions from Jonathon Gagne of Masterpiece Studio about demand, content, and acceleration.Chris Brickler, CEO and co-founder of MyndVR, shares exciting insights of a future with continuous advancements in VR. Tweetables: “You're going to see that the metaverse isn't just about living in this virtual game, it's about, how do we digitally connect with one another better? How do we connect with them in a three-dimensional way that feels more natural, and allows us to connect?” — @BrinxSoftware   [0:40:31] “As I reflect on 2021, I think a lot about adaptability and how it's so important to not only accept limitations, but embrace them, and even celebrate them. Because those limitations are incredible inspiration for innovation.” — @ErikaWoolseyPhD  [0:17:35]Links Mentioned in Today's Episode: Inga Petryaevskaya on LinkedIn  Tvori  Dr. Ramses Alcaide on LinkedIn  NeurableGabriel Jones on LinkedIn  Proprio Vision Erika Woolsey on LinkedIn  The Hydrous Kyle Jackson on LinkedIn Talespin  Anurupa Ganguly on LinkedIn Prisms of Reality Keita Funakawa on LinkedInNanomeJonathan Gagne on LinkedInMasterpieceVR Chris Brickler on LinkedInMyndVRPearly Chen on TwitterVIVE

Here today to unpack how immersive interfaces support drug research and development is Keita Funakawa, founder and COO of Nanome. Join us to hear about the first application that Nanome set out to mainstream; drug discovery, and how they are bringing their vision to bring science into a collaborative, intuitive, and obvious space. You'll also learn about Harvard's study into how VR can support chemistry education, and what it has been like for Keita to work with big pharmaceutical companies with a product he built right out of school. We touch on quantum computing, and discuss the COVID19 supercomputing project Nanome has been involved with, before talking about the AI generated potential therapeutics analyzed by humans in virtual reality. Nanome reaches far and wide, from being used to analyze battery cells, to integrations in the food and beverage industry. Keita shares a bit about these relationships, and reveals the details of his funding journey during the pandemic. We hope you join us to hear all this and more today!  Key Points From This Episode:The first application that Nanome set out to mainstream: drug discovery.An introduction to our guest, Keita Funakawa.Nanome's vision for what science ought to look like: collaborative, intuitive, and obvious.How education forms part of the vision to lower the barrier to entry to complex data. Harvard's study into how VR can support chemistry education.What it has been like working with big pharmaceutical companies with a product they built just out of school.Nanome's role in enabling scientists to make mistakes early and virtually.How they are starting to integrate with quantum computers and quantum results.The COVID19 supercomputing project that simulates what would happen with different drugs.The AI-generated potential therapeutics for COVID19 analyzed by humans in virtual reality.How Nanome is being used to analyze battery cells.The food and beverage industry's relationship with Nanome's technology.What vision they are building for: a world where everyone has a VR or AR headset.Nanome's investor and funding journey during the pandemic.How seeing Google Hardboard for the first time changed everything for Keita.“We're very mission-driven about what science ought to look like, and we know that science ought to look collaborative, it ought to look intuitive, it ought to look obvious. These are some of the problems, a lot of science isn't like that right now.” — @KeitaWF [0:04:37]“It is very much within our vision and passion to lower the barrier to entry to these types of complex data and science, as a whole. Education has also been a pretty big part of this.” — @KeitaWF [0:05:46]“What does the next generation scientific interface look like when everybody has a VR or AR headset just like they do a smartphone? That's the vision that we're building for.” — @KeitaWF [0:25:00]Links Mentioned in Today's Episode:Keita Funakawa on TwitterKeita Funakawa on InstagramKeita Funakawa on LinkedInNanomeNanome on YouTubePearly Chen on TwitterVIVE

Kamal Ravikant has trekked to one of the highest base camps in the Himalayas, earned the US Army Infantry patch, walked 550 miles across Spain, lived in Paris, and bungee jumped out of a perfectly good hot air balloon. Kamal is the only non-black, non-woman member of the Black Women’s writers’ group. Mr. Ravikant won a San Francisco-wide modeling contest, gotten drunk on the same barstool as Hemingway, co-founded a company with the guy who wrote the first browser, and been fortunate enough to work with some of the smartest investors and engineers in Silicon Valley. Kamal has written 3 books, the latest, Love Yourself Like Your Life Depends on It, went viral. Amazing people all over shared it online and on social media. They bought copies for friends and family. They wrote heartfelt reviews. For some, this book literally saved their lives. For others, it was the first time they ever loved themselves. Thanks to today’s sponsor, LinkedIn Jobs! Visit linkedin.com/impossible to post your job ad for FREE! 00:03:30 Do you see yourself as a scientist? Why do you feel the obligation to teach? 00:09:15 The numerology of your book and the influence of James Altucher. A commitment to writing. 00:14:33 How do you handle the burden of having so many people depending on you? 00:17:33 Discuss the importance of the gym and fitness to you. 00:18:59 A commitment to being honest. And Kamal's painful healing. About pain and loss. 00:26:43 The importance of innocence. 00:34:06 Is "The Practice" the ultimate personal discipline? The importance of calibration. 00:37:01 Do you believe in the adage: "facke it till you make it"? 00:36:03 Humans are feelings first. 00:42:41 What was your mother's influence on you? 00:46:04 Parenting advice. 00:47:37 On blockchain, bitcoin, technology and the purpose of wealth. 00:55:31 Why do people get "religious" about being pro or con about bitcoin? A UC San Diego spinout has taken Brian's suggestion and used the blockchain to document scientific research and discovery. See Stuart Volkow's interview with Nanome.ai Co-Founder Steve McCloskey: https://youtu.be/FSmKRmRq6EU Learn about Matryx here: https://blog.matryx.ai/matryx-calcflow-q2-updates-3c43c058e34d Support the podcast: https://www.patreon.com/drbriankeating And please join my mailing list to get resources and enter giveaways to win a FREE copy of my book (and more) http://briankeating.com/mailing_list.php

In this episode of the podcast we delve into the work of co-host Jessi, who is exploring the research question: Can Augmented Reality help students understand abstract concepts? Jessi shares details about an AR application which she recently published on the Google Playstore - Science On TV. Tim and Jessi also discuss: - The SAMR Model, a theoretical framework, which can be used to categories different degrees of educational technology integration - Nanome. A VR application which is being used by scientists, researchers and pharmaceutical developers www.nanome.ai Download the Science On TV app here: https://play.google.com/store/apps/details?id=com.Charming.ScienceTV

We're on lock down! Last week on March 15th Berkeley, then two days later, the state of California issued a Stay at Home order that moved us from the basement of the matrix and onto Zoom. What is an essential business and does it include cannabis clubs? Will social distancing increase VR adoption or will the supply chain limit VR to industry and early adopters? Are we living in a simulation sparked by alien technology? We contemplate our new reality and re-cap our encounter with an Oculus Rift install bug from 2016 that has us pivoting yet again in search of a way forward. Oculus Forums / Oculus Setup: KB2670838 and KB3033929 required, but already installedBe sure to catch our YouTube playlists for music inspired by the intensity of the moment. The GammaElementsStay home and stay safe everyone!Featured links:NeuroExplorer VR on OculusExploring Cornonavirus molecules in VR, CDC YouTubeNanome on Oculus, nanoscale design / get covid-19 model via the PDB code 6LU7. Nanome is free to download through Oculus, Steam, Sidequest, or nanome.ai/setupVRChat on OculusRecRoom on OculusHappy Installing!Siciliana and Melanie

   https://nanome.ai/ @StevenMcCloskey Steve McCloskey is an Alumni from the first class of Nanoengineering at the University of California, San Diego. Steve’s work is focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics (STEM). During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center and developing thermodynamic processing methods for Iron-based Superelastic alloys. After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and Engineers working at the nanoscale, specifically protein engineering and small molecule drug development. Steve is also a founder of the Matryx blockchain platform which provides a secure framework for collaborative design and development for STEM. Nanome is transforming how we interact with and understand science, creating a virtual world where users can experiment, design and learn at the nanoscale. We’re building an open platform to solve age-old problems of collaboration, incentivization and siloed information – creating a world with open access to science & technology. Learn more about your ad choices. Visit megaphone.fm/adchoices

Steve McCloskey is an Alumni from the first class of Nanoengineering at the University of California, San Diego. Steve’s work is focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics (STEM). During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center and developing thermodynamic processing methods for Iron-based Superelastic alloys. After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and Engineers working at the nanoscale, specifically protein engineering and small molecule drug development. Steve is also a founder of the Matryx blockchain platform which provides a secure framework for collaborative design and development for STEM. Nanome is transforming how we interact with and understand science, creating a virtual world where users can experiment, design and learn at the nanoscale. We’re building an open platform to solve age-old problems of collaboration, incentivization and siloed information – creating a world with open access to science & technology.

Dr. Zoran Radic is a scientist working at the School of Pharmacy and Pharmaceutical Science at UC San Diego, where he focuses his research on nerve agents and the development of good antidotes that have the ability to treat or even prevent nerve gas toxicity. He's using a tool from a company by the name Nanome that allows for virtual reality 3D visualization and analysis of molecules that could function as antidotes to a range of toxic substances. He explains that this tool allows scientists to observe and examine with the natural senses compounds that are microscopic, which is opening the door to an unprecedented level of understanding of the ways nerve agents and antidotes interact in the body and with one another. On today's episode, Dr. Radic also discusses the mechanisms of the most common nerve agents that effectively disable normal neurotransmission in our bodies, which means disabling our ability to control bodily movements and breathe. He explains why developing antidotes has been so challenging, how the Nanome 3D tool is aiding in this process, his research on a particular class of substances that could treat a wide range of toxicities, and what he predicts will happen over the next few years in this exciting field of research. Find out more info about Dr. Radic's work at https://profiles.ucsd.edu/zoran.radic

The convergence of information technology with the life sciences is opening up new ways of approaching the challenges of drug discovery and development. While much has been made about approaches that seek to leverage artificial intelligence, Nanome is bringing virtural reality into the process. With the company's technology, scientists can take a fantastic journey to view and manipulate proteins, compounds, and other molecules at a nanoscale. We spoke to Steve McCloskey, founder and CEO of Nanome, about the company's virtual reality platform, how scientists can use it to collaborate in real time, and its potential to change the way researchers discover and develop drugs.

*** this is not financial or legal advice*** Nanome is transforming how we interact with and understand science, creating a virtual world where users can experiment, design and learn at the nanoscale. We're building an open platform to solve age old problems of collaboration, incentivization and siloed information – creating a world with open access to science & technology. Show Links: CRYPTO101podcast.com Patreon: www.patreon.com/user?u=8429526 Twitter: twitter.com/Crypto101Pod twitter.com/BrycePaul101 twitter.com/PizzaMind www.instagram.com/crypto_101 Facebook: https://www.facebook.com/groups/101Crypto/ https://www.facebook.com/CRYPTO101Podcast/ **THIS IS NOT FINANCIAL OR LEGAL ADVICE** © Copyright 2019 Boardwalk Flock, LLC All Rights Reserved Music: https://www.youtube.com/watch?v=bZq3pqrRcKY Redeem by Mona Wonderlick https://soundcloud.com/monawonderlick Creative Commons — Attribution 3.0 Unported — CC BY 3.0 http://creativecommons.org/licenses/b... Music promoted by Audio Library https://youtu.be/bZq3pqrRcKYAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Sign up for our newsletter at https://Evolvement.io. Evolvement is a podcast hosted by Nye that revolves around Bitcoin, cryptocurrency, blockchain technology, and how these play a role in the current financial models and economic systems of the world. In this episode, Matthew from Crypto 101 Podcast and I team up to interview Steven McCloskey, Founder of Nanome. We sit down to discuss the future of VR technology and the many ways it can be used for educational purposes. We also chat about quantum computer and other realms of technology that VR can affect. Finally, we discuss how VR can be tied in with blockchain technology. Learn more about Nanome at https://nanome.ai/. Thank you to Steven for his time. Also, thank you to our sponsor Unification. And thank you to all our listeners! You guys help make this possible. Timestamps: 1:15 - Who are you and what are you building? 1:50 - What is your background that supports this movement? 2:40 - What is the goal of the company? 3:40 - Will VR help us learn easier? 8:00 - How do you think VR will be used for education?

*** this is not financial or legal advice*** Nanome is transforming how we interact with and understand science, creating a virtual world where users can experiment, design and learn at the nanoscale. We’re building an open platform to solve age old problems of collaboration, incentivization and siloed information – creating a world with open access to science & technology. Show Links: CRYPTO101podcast.com Patreon: www.patreon.com/user?u=8429526 Twitter: twitter.com/Crypto101Pod twitter.com/BrycePaul101 twitter.com/PizzaMind www.instagram.com/crypto_101 Facebook: https://www.facebook.com/groups/101Crypto/ https://www.facebook.com/CRYPTO101Podcast/ **THIS IS NOT FINANCIAL OR LEGAL ADVICE** © Copyright 2019 Boardwalk Flock, LLC All Rights Reserved Music: https://www.youtube.com/watch?v=bZq3pqrRcKY Redeem by Mona Wonderlick https://soundcloud.com/monawonderlick Creative Commons — Attribution 3.0 Unported — CC BY 3.0 http://creativecommons.org/licenses/b... Music promoted by Audio Library https://youtu.be/bZq3pqrRcKY

In this episode I sit down with Vinay Gupta, Mattereum co-founder, refugee shelter designer, Ethereum blockchain innovator, venture capitalist and one of the great minds in the crypto space. We talk about what Mattereum is focused on now, making smart contracts work for property and then we launch into the deep future, philosophy and why zksnarks will eat the world. The post Interview with Steve McCloskey of Nanome appeared first on Daily Posthuman.

Hello and welcome to another episode of the Enter VR podcast featuring Steve McClosky from Nanome VR. Join us for a discussion on VR, nanoengineering and the limits of technology! Show Notes 30: What is Nanome? What is Steve working on? 1:40 How did Steve reach the intersection between VR and Nanotechnology? 5:00 What is the current nanotechnology industry landscape. 11:00 What are the counterarguments of combining VR with nanotech? 15:00 What have been successful user acquisition strategies? 16:50 What is the grand vision for Nanome? 25:40 How do you minimize bad actors in a population of people with the ability to design materials at a nanoscale? 27:00 What are the limits of nanotechnology? 32:00 The most exciting trends in the vr industry for the next 6 months to 1 year. 42:00 The hype behind Neural link. 48:00 How to stay in touch with Steve Message hello@nanome.ai for an enterVR podcast discount! 49:40 Topics for the next conversation! Stay in touch with the links below: https://twitter.com/nanome_inc https://twitter.com/StevenMcCloskey https://nanome.ai/

Steve McCloskey, founder, and CEO of Nanome (nanome.ai) delivers an interesting overview of their virtual reality solutions for scientists and engineers—solutions that could potentially stimulate discovery of disease treatment and even cure. McCloskey studied nanoengineering at the University of California, San Diego where his work was primarily focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics (STEM). While at UC San Diego, McCloskey worked with Ken Vecchio, the founding chair of the nanoengineering department, as they set the foundation for the Nanoengineering Materials Research Center. They were instrumental in the development of thermodynamic processing methods for iron-based superelastic alloys. McCloskey's passion for the field led him to launch Nanome as a vehicle to build virtual reality solutions for scientists and engineers working at the nanoscale. Specifically, Nanome's team spends a significant amount of time exploring protein engineering and small molecule drug development.  McCloskey's company, Nanome, transforms our interaction with, and understanding of, science, by providing a virtual world where users can experiment, design, innovate and learn at the nanoscale. McCloskey explains that Nanome's vision is to create an immersive interface where people can see things intuitively, and better interact with science via virtual reality and other tools. McCloskey states that their current technology allows users to view at the atom level, but he is working to develop further, to achieve success at the subatomic level. Additionally, he discusses the energy minimization force field as it relates to forces that are being calculated between atoms as they push and pull apart.  McCloskey discusses one of their top products that he is particularly excited about—CalcFlow. CalcFlow allows researchers to study and visualize vector calculus in an interactive environment. The platform enables mathematical modeling, manipulation of 3D graphs, as well as the editing of parameters while you work. He elaborates on the advantages that CalcFlow provides for research and experimentation, such as its ability to bring mechanical engineering design into the dynamic in an observable manner. And the process is exceptionally great for optimization and delivery into the 3D printing environment. The nanoengineering expert describes how the introduction of blockchain to their platform will allow more people to work globally toward solutions to many problems that humans face, from technology to medical and beyond. McCloskey details how the platform can provide an opportunity for a larger group of people to study and hopefully find solutions for tropical diseases, diseases that big pharmaceutical companies have no interest in, due to the fact that their ability to profit is lower. Through the use of open-source models and automated licensing, and even closed source, the use of blockchain truly is changing the rate of discovery, as the global community can be involved.  As the technology is expanding, McCloskey expects that virus modeling will become easier, as entire viruses can be viewed with atomic detail, enabling study at the systems level of the biology. And by simulating cells at every level, the possibilities for discovery are enormous.

Nanome CEO joins Az and Petr to talk about Chemistry and Math education and drug designs in VR. Topics discussed: - 3d Math visualizations in VR - 3d Chemistry education in VR - Protein designs on the blockchain recorded: July 2018